M.J. Carr

674 total citations
18 papers, 586 citations indexed

About

M.J. Carr is a scholar working on Organic Chemistry, Genetics and Molecular Biology. According to data from OpenAlex, M.J. Carr has authored 18 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 7 papers in Genetics and 6 papers in Molecular Biology. Recurrent topics in M.J. Carr's work include Synthesis of β-Lactam Compounds (8 papers), Estrogen and related hormone effects (7 papers) and Cancer therapeutics and mechanisms (6 papers). M.J. Carr is often cited by papers focused on Synthesis of β-Lactam Compounds (8 papers), Estrogen and related hormone effects (7 papers) and Cancer therapeutics and mechanisms (6 papers). M.J. Carr collaborates with scholars based in Ireland, Australia and Singapore. M.J. Carr's co-authors include Mary J. Meegan, Daniela M. Zisterer, David G. Lloyd, Lisa M. Greene, Andrew J. S. Knox, Niamh M. O’Boyle, Seema M. Nathwani, Michael P. Carty, Fawaz Aldabbagh and Thomas McCabe and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Biochemical Pharmacology.

In The Last Decade

M.J. Carr

18 papers receiving 581 citations

Peers

M.J. Carr
Manolis A. Fousteris Greece
Sotiris S. Nikolaropoulos Greece
Anna I. Koutsourea Greece
Christopher M. Tegley United States
Rita Fiaschi Italy
Zhiye Hu China
Candido Gude United States
P. CATSOULACOS Greece
Ravi K. Varma United States
Jingle Xi China
Manolis A. Fousteris Greece
M.J. Carr
Citations per year, relative to M.J. Carr M.J. Carr (= 1×) peers Manolis A. Fousteris

Countries citing papers authored by M.J. Carr

Since Specialization
Citations

This map shows the geographic impact of M.J. Carr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.J. Carr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.J. Carr more than expected).

Fields of papers citing papers by M.J. Carr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.J. Carr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.J. Carr. The network helps show where M.J. Carr may publish in the future.

Co-authorship network of co-authors of M.J. Carr

This figure shows the co-authorship network connecting the top 25 collaborators of M.J. Carr. A scholar is included among the top collaborators of M.J. Carr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.J. Carr. M.J. Carr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Carr, M.J., Andrew J. S. Knox, Niamh M. O’Boyle, et al.. (2019). Optimisation of estrogen receptor subtype-selectivity of a 4-Aryl-4H-chromene scaffold previously identified by virtual screening. Bioorganic & Medicinal Chemistry. 28(5). 115261–115261. 4 indexed citations
2.
O’Boyle, Niamh M., Irene Barrett, Lisa M. Greene, et al.. (2017). Lead Optimization of Benzoxepin-Type Selective Estrogen Receptor (ER) Modulators and Downregulators with Subtype-Specific ERα and ERβ Activity. Journal of Medicinal Chemistry. 61(2). 514–534. 33 indexed citations
3.
4.
Carr, M.J., Andrew J. S. Knox, David G. Lloyd, Daniela M. Zisterer, & Mary J. Meegan. (2016). Development of the β-lactam type molecular scaffold for selective estrogen receptor α modulator action: synthesis and cytotoxic effects in MCF-7 breast cancer cells. Journal of Enzyme Inhibition and Medicinal Chemistry. 31(sup3). 117–130. 4 indexed citations
5.
O’Boyle, Niamh M., M.J. Carr, Andrew J. S. Knox, et al.. (2014). β-Lactam Estrogen Receptor Antagonists and a Dual-Targeting Estrogen Receptor/Tubulin Ligand. Journal of Medicinal Chemistry. 57(22). 9370–9382. 49 indexed citations
6.
Verma, Navin Kumar, et al.. (2014). Combretastatin (CA)-4 and its novel analogue CA-432 impair T-cell migration through the Rho/ROCK signalling pathway. Biochemical Pharmacology. 92(4). 544–557. 14 indexed citations
7.
Hughes, Linda, Lisa M. Greene, M.J. Carr, et al.. (2012). Novel cis-restricted β-lactam combretastatin A-4 analogues display anti-vascular and anti-metastatic properties in vitro. Oncology Reports. 29(2). 585–594. 17 indexed citations
8.
Caboni, Laura, Gemma K. Kinsella, Fernando Blanco, et al.. (2012). “True” Antiandrogens—Selective Non-Ligand-Binding Pocket Disruptors of Androgen Receptor–Coactivator Interactions: Novel Tools for Prostate Cancer. Journal of Medicinal Chemistry. 55(4). 1635–1644. 46 indexed citations
9.
O’Boyle, Niamh M., M.J. Carr, Lisa M. Greene, et al.. (2011). Synthesis, biochemical and molecular modelling studies of antiproliferative azetidinones causing microtubule disruption and mitotic catastrophe. European Journal of Medicinal Chemistry. 46(9). 4595–4607. 38 indexed citations
10.
11.
O’Donovan, Liz, et al.. (2010). The influence of the aziridinyl substituent of benzimidazoles and benzimidazolequinones on toxicity towards normal and Fanconi anaemia cells. European Journal of Medicinal Chemistry. 45(5). 1873–1879. 30 indexed citations
12.
Carr, M.J., et al.. (2010). Synthesis and toxicity towards normal and cancer cell lines of benzimidazolequinones containing fused aromatic rings and 2-aromatic ring substituents. European Journal of Medicinal Chemistry. 45(9). 3762–3769. 62 indexed citations
13.
Carr, M.J., Lisa M. Greene, Andrew J. S. Knox, et al.. (2010). Lead identification of conformationally restricted β-lactam type combretastatin analogues: Synthesis, antiproliferative activity and tubulin targeting effects. European Journal of Medicinal Chemistry. 45(12). 5752–5766. 63 indexed citations
14.
O’Boyle, Niamh M., M.J. Carr, Lisa M. Greene, et al.. (2010). Synthesis and Evaluation of Azetidinone Analogues of Combretastatin A-4 as Tubulin Targeting Agents. Journal of Medicinal Chemistry. 53(24). 8569–8584. 111 indexed citations
15.
Greene, Lisa M., Seema M. Nathwani, Sandra A. Bright, et al.. (2010). The Vascular Targeting Agent Combretastatin-A4 and a Novel cis-Restricted β-Lactam Analogue, CA-432, Induce Apoptosis in Human Chronic Myeloid Leukemia Cells and Ex Vivo Patient Samples Including Those Displaying Multidrug Resistance. Journal of Pharmacology and Experimental Therapeutics. 335(2). 302–313. 26 indexed citations
16.
Barrett, Irene, M.J. Carr, Niamh M. O’Boyle, et al.. (2010). Lead identification of conformationally restricted benzoxepin type combretastatin analogs: synthesis, antiproliferative activity, and tubulin effects. Journal of Enzyme Inhibition and Medicinal Chemistry. 25(2). 180–194. 13 indexed citations
17.
Barrett, Irene, Mary J. Meegan, M.J. Carr, et al.. (2008). Synthesis, biological evaluation, structural–activity relationship, and docking study for a series of benzoxepin-derived estrogen receptor modulators. Bioorganic & Medicinal Chemistry. 16(21). 9554–9573. 43 indexed citations
18.
Meegan, Mary J., M.J. Carr, Andrew J. S. Knox, Daniela M. Zisterer, & David G. Lloyd. (2008). β-Lactam type molecular scaffolds for antiproliferative activity: Synthesis and cytotoxic effects in breast cancer cells. Journal of Enzyme Inhibition and Medicinal Chemistry. 23(5). 668–685. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manolis A. Fousteris Breakdown of academic impact, for papers by Sotiris S. Nikolaropoulos Breakdown of academic impact, for papers by Anna I. Koutsourea Breakdown of academic impact, for papers by Christopher M. Tegley Breakdown of academic impact, for papers by Rita Fiaschi Breakdown of academic impact, for papers by Zhiye Hu Breakdown of academic impact, for papers by Candido Gude Breakdown of academic impact, for papers by P. CATSOULACOS Breakdown of academic impact, for papers by Ravi K. Varma Breakdown of academic impact, for papers by Jingle Xi
Rankless by CCL
2026